Retrieve available abstracts of 1 articles: HTML format
Single Articles
September 2024
FRIEDMAN JH In early Parkinson disease, daily subcutaneous lixisenatide reduced motor
disability progression at 12 mo.
Ann Intern Med. 2024 Sep 3. doi: 10.7326/ANNALS-24-01662. PubMedAbstract available